fbpx

Get ready for an exciting announcement for the melanoma community

  • Days
  • Hours
  • Minutes

News & Press


Early ctDNA Testing Provides Another Tool for Predicting Survival Outcomes With Tebentafusp in Metastatic Uveal Melanoma

May 9, 2023

The incorporation of circulating tumor DNA (ctDNA) testing into standard practice for patients with metastatic uveal melanoma receiving tebentafusp-tebn (Kimmtrak) may provide a more accurate assessment of the agent’s efficacy compared with radiographi …



#EyeGetDilated for Melanoma Awareness Month: Karen Kaludov

May 3, 2023

Guest blog by Karen Kaludov, an ocular melanoma survivor and advocate who shares her journey after her recent diagnosed in 2021:   Roughly 2,000 people in the US each year are diagnosed with ocular melanoma (OM). In 2021, I became one of them. Whe …



Melanoma Awareness Month: Patrick Guddal

May 3, 2023

Guest blog by Patrick Guddal, a stage 3 melanoma survivor and advocate who shares his journey after being diagnosed in 2016: In the spring of 2016, I felt a small bump on my scalp. I didn’t think much of it. I figured I scratched myself in my sleep. In …



WCVB Channel 5 Chronicle Reporter and Producer Nicole Estaphan to Emcee Melanoma Research Foundation’s Miles for Melanoma 5K

May 2, 2023

New England, MA (May 2, 2023) – The Melanoma Research Foundation (MRF) is thrilled to announce that WCVB Channel 5 Chronicle Reporter and Producer Nicole Estaphan will be returning as the event emcee for the annual Miles for Melanoma New England 5K eve …



MRF Breakthrough Consortium Leaders & MRF-Supported Researchers Named AACR Fellows

May 1, 2023

The American Association of Cancer Research (AACR) recently named a current and former member of the MRF Breakthrough Consortium as Fellows in the AACR Academy. MRF-supported researchers Keith Flaherty, MD and Jedd Wolchok, MD, PhD were recognized as d …